Cite Filings / CLDX
Feed Companies Filings Check
Sign in

CIK 0000744218

  • Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133191702
Phone
+1 908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
Filings Financials Insiders Search text
All 1,299 Financials 377 Shareholder Meetings 36 Executive Compensation 308 Insider Trading 516 Beneficial Ownership Interest 202 Business Combinations 260 Public Offerings 104 Mutual Funds and ETFs 32 Others 75
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2006-04-19
  3. DEF 14A Proxy Proxy Statement 2005-04-22
  4. DEF 14A Proxy Proxy Statement 2004-04-12
  5. DEF 14A Proxy Proxy Statement 2003-04-02
  6. DEF 14A Proxy Proxy Statement 2002-03-28
  7. DEF 14A Proxy Proxy Statement 2001-04-03
  8. DEF 14A Proxy Proxy Statement 2000-03-28
  9. DEF 14A Proxy Proxy Statement 1999-04-01
  10. DEF 14A Proxy Proxy Statement 1998-04-13
  11. DEF 14A Proxy Proxy Statement 1997-04-11
  12. DEF 14A Proxy Proxy Statement 1996-04-15
  13. DEF 14A Proxy Proxy Statement 1995-04-06

Page 2 of 2 · 32 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…